Bio Techne Corp Stock Investor Sentiment
| TECH Stock | USD 60.34 0.55 0.90% |
Under 68% of Bio Techne's investor base is looking to short. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that many investors are alarmed at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.
Comfort Level 32
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bio Techne's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bio Techne Corp.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Bio Historical Sentiment
Although Bio Techne's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bio, such as negative comments on social media and news outlets, may cause fear in the market and push Bio Techne's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bio.
Bio |
Bio Techne Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Bio Techne can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bio Techne Corp Historical Investor Sentiment
Investor biases related to Bio Techne's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Techne Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Techne's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Techne and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bio Techne news discussions. The higher the estimate score, the more favorable the investor's outlook on Bio Techne.
Far too much social signal, news, headlines, and media speculation about Bio Techne that are available to investors today. That information is available publicly through Bio media outlets and privately through word of mouth or via Bio internal channels. However, regardless of the origin, that massive amount of Bio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bio Techne news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bio Techne relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bio Techne's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bio Techne alpha.
Bio Techne Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Rachel Reeves will listen to millionaires but not farmers and pensioners | 01/24/2025 |
2 | Disposition of 13392 shares by Kim Kelderman of Bio Techne at 37.7 subject to Rule 16b-3 | 01/27/2025 |
3 | Techne Fiscal Q2 Earnings Snapshot | 02/05/2025 |
4 | Disposition of 1976 shares by Herr Amy E. of Bio Techne at 44.33 subject to Rule 16b-3 | 02/14/2025 |
5 | EXEL or TECH Which Is the Better Value Stock Right Now | 02/24/2025 |
| Bio Techne dividend paid on 28th of February 2025 | 02/28/2025 |
7 | Q4 Earnings Highlights Thermo Fisher Vs The Rest Of The Research Tools Consumables Stocks | 03/05/2025 |
8 | Reforms surge in polls grinds to a halt as Farage faces party rift over messianic leadership style | 03/06/2025 |
9 | Bio-Techne Lowered to Hold Rating by StockNews.com | 03/11/2025 |
10 | Acquisition by William Geist of 7869 shares of Bio Techne subject to Rule 16b-3 | 03/12/2025 |
11 | Just nine of 29 Reform defectors unveiled in Farages special announcement are new | 03/17/2025 |
Complementary Tools for Bio Stock analysis
When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |